Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | -2.44% | -9.99% | -25.93% |
May. 14 | Transcript : Alimera Sciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Alimera Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 105M | Sales 2025 * | 121M | Capitalization | 168M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | 11M | EV / Sales 2024 * | 1.59 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.38 x |
P/E ratio 2024 * |
-30.5
x | P/E ratio 2025 * |
16.3
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.85% |
Latest transcript on Alimera Sciences, Inc.
1 day | -2.44% | ||
1 week | -9.99% | ||
Current month | -13.04% | ||
1 month | -6.98% | ||
3 months | -6.43% | ||
6 months | -3.03% | ||
Current year | -25.93% |
Managers | Title | Age | Since |
---|---|---|---|
David Holland
FOU | Founder | 60 | 03-06-03 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Pizzo
BRD | Director/Board Member | 57 | 10-03-31 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 3.2 | -2.44% | 43,487 |
24-05-16 | 3.28 | +0.31% | 62,448 |
24-05-15 | 3.27 | -0.30% | 61,001 |
24-05-14 | 3.28 | -5.75% | 150,794 |
24-05-13 | 3.48 | -2.11% | 49,197 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.93% | 168M | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- ALIM Stock